PHYTOCHEMICAL AND NEUROPROTECTIVE INVESTIGATION ON FERULA HERMONIS by Raafat, Karim
BAU Journal - Health and Wellbeing 
Volume 1 Issue 2 
ISSN: 2617-1635 Article 3 
April 2019 
PHYTOCHEMICAL AND NEUROPROTECTIVE INVESTIGATION ON 
FERULA HERMONIS 
Karim Raafat 
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Lebanon, 
k.raafat@bau.edu.lb 
Follow this and additional works at: https://digitalcommons.bau.edu.lb/hwbjournal 
 Part of the Architecture Commons, Business Commons, Life Sciences Commons, and the Medicine 
and Health Sciences Commons 
Recommended Citation 
Raafat, Karim (2019) "PHYTOCHEMICAL AND NEUROPROTECTIVE INVESTIGATION ON FERULA 
HERMONIS," BAU Journal - Health and Wellbeing: Vol. 1 : Iss. 2 , Article 3. 
Available at: https://digitalcommons.bau.edu.lb/hwbjournal/vol1/iss2/3 
This Article is brought to you for free and open access by Digital Commons @ BAU. It has been accepted for 
inclusion in BAU Journal - Health and Wellbeing by an authorized editor of Digital Commons @ BAU. For more 
information, please contact ibtihal@bau.edu.lb. 
PHYTOCHEMICAL AND NEUROPROTECTIVE INVESTIGATION ON FERULA 
HERMONIS 
Abstract 
Ferula hermonis (F. hermonis, Fh) is one of the important medicinal-plants cultivated in Lebanon. The aim 
of this study is to phytochemically-investigate F. hermonis and its most active compound(s) and to explore 
their neuroprotective potentials utilizing an in vivo model of glycine receptor. HPLC-DAD investigation 
was done to identify F. hermonis phytochemical constituents. Combined chromatographic, bio-guided 
fractionation, and in vivo model of glycine receptor were utilized to identify its most active constituent(s). 
HPLC has shown that F. hermonis has shown 11 major peaks identified as: (1) Jaeskenin (2.47%), (2) 
Acetoxy-Ferutinin (3.71%), (3) Lapiferin (4.95%), (4) Siol anisate (6.16%), (5) Fertidin (7.38%), (6) Ferutinin 
(24.60%), (7) p-Coumariloxy jaekeanadiol (7.29%), (8) Akiferin (5.98%), (9) Ferulenol (23.7%), (10) Ferutidin 
(4.68%), and (11) Jaekeanadiol benzoate (6.03%). Ferutinin (Ft) was identified as the most active 
constituent in F. hermonis. The novelty in this work that F. hermonis has shown neuroprotective potentials 
utilizing an ICV, for the first time, in the in-vivo model of glycine receptor. Ft has shown more significant (p˂ 
0.05) neuroprotective potentials than F. hermonis. It could be concluded that F. hermonis has significant 
neuroprotective potentials and that Ft might be responsible for this activity. 
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ABSTRACT: Ferula hermonis (F. hermonis, Fh) is one of the important medicinal-plants 
cultivated in Lebanon. The aim of this study is to phytochemically-investigate F. hermonis and its 
most active compound(s) and to explore their neuroprotective potentials utilizing an in vivo model 
of glycine receptor. HPLC-DAD investigation was done to identify F. hermonis phytochemical 
constituents. Combined chromatographic, bio-guided fractionation, and in vivo model of glycine 
receptor were utilized to identify its most active constituent(s). HPLC has shown that F. hermonis 
has shown 11 major peaks identified as: (1) Jaeskenin (2.47%), (2) Acetoxy-Ferutinin (3.71%), (3) 
Lapiferin (4.95%), (4) Siol anisate (6.16%), (5) Fertidin (7.38%), (6) Ferutinin (24.60%), (7) p-
Coumariloxy jaekeanadiol (7.29%), (8) Akiferin (5.98%), (9) Ferulenol (23.7%), (10) Ferutidin 
(4.68%), and (11) Jaekeanadiol benzoate (6.03%). Ferutinin (Ft) was identified as the most active 
constituent in F. hermonis. The novelty in this work that F. hermonis has shown neuroprotective 
potentials utilizing an ICV, for the first time, in the in-vivo model of glycine receptor. Ft has shown 
more significant (p˂ 0.05) neuroprotective potentials than F. hermonis. It could be concluded that 
F. hermonis has significant neuroprotective potentials and that Ft might be responsible for this 
activity. 
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1. INTRODUCTION 
Medicinal plants traditionally have shown superiority in the management of several disorders, especially the 
neurological and chronic disorders (Deventer, Pozo, Van Eenoo, & Delbeke, 2007). 
Ferula hermonis (F. hermonis, F. Apiaceae) is one of the important medicinal plants cultivated in Lebanon 
(Raafat, 2016; Raafat & El-Lakany, 2015). F. hermonis comprises several phytochemical compounds that have 
not been widely explored. F. hermonis has been traditionally used for erectile dysfunction and several neurological 
disorders (Raafat, 2013). Phytochemical analyses have shown that F. hermonis comprises daucane-aryl-esters like 
ferutinin (Ft) (Galal, 2000; Lhuillier et al., 2005). Ft has various pharmacological-activities including estrogenic 
and hypoglycemic activities (Raafat, 2013). Ft is one of the potent natural phyto-estrogen which has potentiating-
activity on estrogen-receptors, especially alpha-receptor. It seems that Ft plays an important role in F. hermonis 
pharmacological-activities, chiefly the useful-effects of this plant on diabetes, impotence, osteoporosis and 
inflammation (Al-Ja'fari et al., 2011; Allouh, 2011; Geroushi et al., 2011; Ibraheim et al., 2012; Sattar & Iranshahi, 
2017). 
Glycine receptor is one of the important ion channels responsible for neuro-stability. It possesses an inhibitory 
response to neuron cells guarding against neurotoxicity (Raafat, Breitinger, Mahran, Ayoub, & Breitinger, 2010). 
Intracerebroventricular (ICV) procedures have been established to be a distinguished in vivo method in discovering 
GlyR-modulators (Raafat & Wurglics, 2018). 
Therefore, the aim of this study is to phytochemically-investigate F. hermonis and its most active compound(s) 
and to explore their neuroprotective potentials utilizing an ICV in vivo model of glycine receptor. 
 
2. EXPERIMENTAL 
2.1 Standards and Solvents 
All standards and solvents (analytical grade) have been purchased from Sigma-Aldrich (Germany) (Saleh, El-
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2.2 Extraction 
Ferula hermonis roots were acquired from Ibn Al-Nafess (Lebanon). The roots have been compared to an 
original sample, and a representative aliquot has been placed in the Faculty herbarium with a voucher-specimen 
no. (PS-17-35). 
The roots were sonicated for 3h with acetone and then filtered, and dried using a rotary-evaporator (40°C under-
vacuum), and the extract was kept under -4 °C until further use. 
 
2.3 Chromatography 
2.3.1 RP-HPLC method 
The Jasco HPLC system (Japan) (Raafat, Wurglics, & Schubert-Zsilavecz, 2016) consisted of a pump and a C18 
stationary phase column was used for chromatographic separations. The eluent comprised MeOH/Phosphate buffer 
pH 2.41 (50:50 v/v) at flow-rate of one mL/min at 202 nm maintained at 40°C. 
 
2.3.2 Phytochemical bio-guided fractionation and identification method 
F. hermonis extract has been fractionated utilizing a preparative column-chromatography (CC) (50 mm * 100 
cm) utilizing RP-silica-gel and eluted in elevating polarity with MeOH-Ethyl acetate (0:100, 5:95, 10:90, 20:80, 
30:70, 50:50,70:30, 80:20, 90:10, 100:0v/v). During the whole RP-CC process the mobile phase has been collected 
by time in a sequence of more than two hundred fractions. Similar samples were combined and concentrated and 




 After 7 days of accommodation in standard-cages, male Swiss-Webster mice (BAU, Lebanon) have had open-
entrance to standard food and water. Animal-care and experiments were done abiding by the animal experiment-
legislations and with the approval of BAU-Institutional Review Board (2014A-004-P-R-0006).  
 
2.5 Loss of the Righting Reflex (LORR) in vivo Experimentation 
It was described before that the extract/active compound combined with glycine (gly) when administered 
intracerebroventricularly (ICV) might augment the EtOH central-inhibitory activity if the extract/active compound 
was GlyR potentiator, and inhibited with GlyR blockers like strychnine (Raafat & Wurglics, 2018; Williams Kl 
Fau - Ferko, Ferko Ap Fau - Barbieri, Barbieri Ej Fau - DiGregorio, & DiGregorio, 1995). 
In the EtOH presence, gly alone or combined with Fh (25, 50 or 100 mg/kg), or Ft (6.25, 12.5 or 25 mg/kg) have 
been ICV-injected. The approach of this procedure was that Fh or Ft might potentiate or block gly-potentiated 
EtOH central-depressant activities. Strychnine, a GlyR blocker, was ICV-injected after the administration of gly 
alone or combined to verify Fh or Ft neuroactive mechanism. 
Bicuculline (Bic), a GABAA-receptor inhibitor, was ICV-infused after the administration of gly alone or 
combined to assure that GlyR is the only operating receptor (Williams Kl Fau - Ferko et al., 1995). 
The loss of righting reflex (LORR) has been utilized to evaluate the level of central-inhibition produced by 
EtOH using a procedure reported before (Raafat & Wurglics, 2018; Williams Kl Fau - Ferko et al., 1995). In brief, 
each animal (n=4/group) received EtOH (20%, 4.0 gm/kg) as an intraperitoneal (i.p.) injection intended to LORR-
induction (Wallgren & Barry, 1970). The time to LORR (seconds), is the duration from injection to the EtOH-
induced LORR. Whilst the LORR-end (min.), is the capability of the animals to right themselves by rotating-
backward to their paws 3 times in 15 seconds when located backwards. Furthermore, the EtOH-LORR is the time 
between the initial-LORR and the subsequent righting-reflex (RR) regaining was reported. After test ICV-
injections, a second-period of LORR was recorded. This 2nd-period was recognized as the return to LORR, which 
is the period between ICV-injection and the subsequent regaining of RR. 
 
2.6 ICV Extract/Active Constituent Administration 
After 20 min after the animal lost the RR, a sagittal incision has been done on the posterior-part of the animal-
head revealing the skull-sutures. Previously EtOH-anesthetized animal an opening three mm in depth was made 
two mm dorsal to the bregma-suture and two mm dorsal to the sagittal-suture utilizing a twenty four gauge-needle. 
Following the mice regaining the RR after the injection of EtOH, they had an intracerebroventricular-injection 
over a period of ten seconds of saline or extract/active constituent (with a total volume of ten µl). Consequent with 
ICV-injection of saline or extract/active constituent, a second-LORR has been reported (return to LORR) 
(Lundquist, 1959; Raafat & Wurglics, 2018).  
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2.7 Statistics 
The data were recorded as means ± SEM. Upon correlating all values recorded to the control, all test have been 
determined utilizing one way ANOVA test, setting p-values ˂ 0.05 as statistically significant (Ikeda, Dohi, & 
Tsujimoto, 1982; Raafat & Wurglics, 2018; Sawaki et al., 2000). 
 
3. RESULTS AND DISCUSSION 
3.1 Chromatography 
3.1.2 RP-HPLC phytochemical standardization method 
Utilizing the optimized RP-HPLC conditions used in this study, the F. hermonis extract has revealed 11 major 
peaks: (1) Jaeskenin (2.47%), (2) Acetoxy-Ferutinin (3.71%), (3) Lapiferin (4.95%), (4) Siol anisate (6.16%), (5) 
Fertidin (7.38%), (6) Ferutinin (24.60%), (7) p-Coumariloxy jaekeanadiol (7.29%), (8) Akiferin (5.98%), (9) 
Ferulenol (23.7%), (10) Ferutidin (4.68%), and (11) Jaekeanadiol benzoate (6.03%).  (Fig. 1). This method has 




Fig. 1 HPLC-DAD of Ferula hermonis: (1) Jaeskenin (2.47%), (2) Acetoxy-Ferutinin (3.71%), (3) Lapiferin 
(4.95%), (4) Siol anisate (6.16%), (5) Fertidin (7.38%), (6) Ferutinin (24.60%), (7) p-Coumariloxy jaekeanadiol 
(7.29%), (8) Akiferin (5.98%), (9) Ferulenol (23.7%), (10) Ferutidin (4.68%), and (11) Jaekeanadiol benzoate 
(6.03%). The eluent was methanol: pH 2.41 phosphate-buffer (50:50) utilizing 202 nm at 40° C. 
 
3.2 Phytochemical Bio-guided Fractionation and Identification Method 
Depending on the bio-guided isolation and fractionation procedures, the most-active part of F. hermonis extract 
was recognized using RP-HPLC procedure and in vivo model of glycine receptor. The most active fraction major 
peak was recognized as ferutinin (Ft), utilizing standard Ft steeping-method (Raafat et al., 2016).  
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Table 1: Return to Righting Reflex (RR) experiment. 
Test Solution 
Time to return to LORR 
 (min.) 
Vehicle Control 0.01 ± 0.01 
Gly 1 mmol/kg 2.70 ± 0.15 
Gly 15 mmol/kg 13.11 ± 0.75 
Gly 25 mmol/kg 19.00 ± 1.34 
Gly 50 mmol/kg 27.10 ± 1.99 
  
Gly 15 mmol/kg +STR 50 nmol/kg 10.70 ± 0.03 
Gly 15 mmol/kg +STR 100 nmol/kg 2.70 ± 0.08 
Gly 15 mmol/kg +STR 300 nmol/kg 
0.40 ± 0.09 
 
 
3.3 Righting Reflex Loss (LORR) Test 
Animals have shown LORR subsequent to EtOH i.p. injection. The LORR onset was established at 82.98  5.50 
s, and EtOH LORR endured for 33.58  2.30 min. Glycine (gly) has potentiated EtOH CNS-depressant activities 
in animals, as marked by the dose dependant and immediate return to the LORR after gly-ICV injection at different 
doses (Table 1). 
The results in (Table 1) showed that when different doses of strychnine (STR) (50, 100, or 300 nmol/kg) were 
ICV-injected in combination with EC50 gly (15 mol/kg), STR has blocked gly-activities in a dose-dependent 
fashion. 
STR ICV-injection (300 nmol/kg) has totally blocked the gly-activities, suggesting that the strychnine-sensitive 
GlyR is the only functioning receptor (Table 1). 
The data recorded have shown that different doses of Fh (25, 50 and 100 mol/ kg) in combination with gly 15 
mol/ kg, Fh has potentiated gly-effects in a dose-dependent fashion, implying that Fh is a GlyR potentiator (Fig. 
2). 
The data have shown that different doses of Ft (6.25, 12.5 and 25 mol/ kg) in combination with 15 mol/ kg 
gly, Ft also potentiated gly-activities in a dose-dependent manner (Table 1), suggesting Ft as also a potent GlyR 
potentiator (Fig. 2). 
STR (300 nmol/kg), the specific GlyR blocker, combined with gly and Fc (at low doses) abolished Fc 
potentiation responses (Fig. 2). Fh (100 mol/kg, at the highest dose) reversed STR (300 nmol/kg) inhibition (Fig. 
2), empowering the fresult that Fh is a GlyR potentiator, likewise, Ft (25 mol/kg, at the highest dose) also reversed 
STR (300 nmol/kg) blockage (Fig. 2), supporting the results that Ft is a possible GlyR potentiator. Biologically 
active-materials that reverse the STR action have shown to possess anticonvulsant-activities (Hisaoka & Levy, 
1985; Khisti, VanDoren, O'Buckley, & Morrow, 2003; Mascia, Machu, & Harris, 1996; Raafat & Wurglics, 2018). 











































































































































Fig. 2 Return to Righting Reflex (RR) experiment. RR following intracerebroventricular-injection of (Gly 15) 
Glycine 15mmol/kg, (STR 300) STR 300nmol, (Gly 15 + Fh 25) Glycine 15mmol/kg and Fh 25mmol/kg, (Gly 15 
+ Fh 100) Glycine 15mmol/kg and Fh 100mmol/kg, (Gly 15 + Fh 100) Glycine 15mmol/kg and Fh 100mmol/kg, 
(Gly 15 + Ft 6.25) Glycine 15mmol/kg and Ft 6.25mmol/kg, (Gly 15 + Ft 12.5) Glycine 15mmol/kg and Ft 
12.5mmol/kg, (Gly 15 + Ft 25) Glycine 15mmol/kg and Ft 25mmol/kg, (Gly 15 + Fh 25 + STR 300) Glycine 
15mmol/kg, Fh 25mmol/kg and STR 300nmol/kg, (Gly 15 + Fh 50 + STR 300) Glycine 15mmol/kg, Fh 
50mmol/kg and STR 300nmol/kg, (Gly 15 + Fh 100 + STR 300) Glycine 15mmol/kg, Fh 10 mmol/kg and STR 
300nmol/kg, (Gly 15 + Ft 6.25 + STR 300) Glycine 15mmol/kg, Ft 6.25mmol/kg and STR 300nmol/kg, (Gly 15 
+ Ft 12.5 + STR 300) Glycine 15mmol/kg, Ft 12.5mmol/kg and STR 300nmol/kg, or (Gly 15 + Ft 25 + STR 300) 
Glycine 15mmol/kg, Ft 25mmol/kg and STR 300nmol/kg. Results are shown as means ± SEM, “*” represent a 
significant difference (p ˂ 0.05). 
 
Therefore, it could be determined that Fh and Ft were in vivo modulators to the GlyR. Accordingly, the 
intracerebroventricular method has proven to be a trustworthy method for the discovery of GlyR-modulators. 
 
4. CONCLUSIONS 
HPLC has shown that F. hermonis has shown 11 major peaks identified as: (1) Jaeskenin (2.47%), (2) Acetoxy-
Ferutinin (3.71%), (3) Lapiferin (4.95%), (4) Siol anisate (6.16%), (5) Fertidin (7.38%), (6) Ferutinin (24.60%), 
(7) p-Coumariloxy jaekeanadiol (7.29%), (8) Akiferin (5.98%), (9) Ferulenol (23.7%), (10) Ferutidin (4.68%), and 
(11) Jaekeanadiol benzoate (6.03%). Ferutinin (Ft) was identified as the most active constituent in F. hermonis. 
The novelty in this work that F. hermonis has shown neuroprotective potentials utilizing an ICV, for the first time, 
in the in-vivo model of glycine receptor. Ft has shown more significant (p˂ 0.05) neuroprotective potentials than 
F. hermonis. It could be concluded that F. hermonis has significant neuroprotective potentials and that Ft might be 
responsible for this activity.          
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